PacBio (PACB) reports Q3: everything you need to know ahead of earnings
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- PACB Pacific Biosciences Of California
Named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR
Industrial Select Sector SPDR holds the industrials sector that Pacific Biosciences of California belongs to, so it often moves with news about it.
- A Agilent Technologies
Agilent Technologies is a peer of Pacific Biosciences of California in laboratory analytical instruments; rivals often move on the same news.
- WAT Waters
Waters is a peer of Pacific Biosciences of California in laboratory analytical instruments; rivals often move on the same news.
- ILMN Illumina
Illumina is a peer of Pacific Biosciences of California in laboratory analytical instruments; rivals often move on the same news.
- RVTY Revvity
Revvity is a peer of Pacific Biosciences of California in laboratory analytical instruments; rivals often move on the same news.
- AVTR Avantor
Avantor is a peer of Pacific Biosciences of California in laboratory analytical instruments; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| PACB | +4.70% | +24.36% | base | +4.27% | +9.62% | +3.21% | -3.85% |
| XLI | -1.06% | +0.22% | base | +0.95% | -0.17% | -4.14% | -4.16% |
| A | +3.20% | +5.32% | base | +2.02% | +3.02% | -0.14% | +1.62% |
| WAT | +4.21% | +6.80% | base | +2.27% | +4.07% | +0.85% | +1.86% |
| ILMN | +23.35% | +27.87% | base | +5.17% | +0.04% | -8.19% | -5.93% |
| RVTY | +6.78% | +9.26% | base | +7.87% | +5.12% | -0.56% | +2.26% |
| AVTR | +9.68% | +6.89% | base | -0.06% | +0.29% | -2.95% | -0.87% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
PacBio (PACB) reports Q3: everything you need to know ahead of earnings TradingView
Source: TradingView
This story
| Company | When | Move | Status |
|---|---|---|---|
| A | that day | +2.02% | final price |
| A | the next day | +3.02% | final price |
| A | two days later | -0.14% | final price |
| A | three days later | +1.62% | final price |
| A | three days earlier | +5.32% | final price |
| A | five days earlier | +3.20% | final price |
| AVTR | that day | -0.06% | final price |
| AVTR | the next day | +0.29% | final price |
| AVTR | two days later | -2.95% | final price |
| AVTR | three days later | -0.87% | final price |
| AVTR | three days earlier | +6.89% | final price |
| AVTR | five days earlier | +9.68% | final price |
| ILMN | that day | +5.17% | final price |
| ILMN | the next day | +0.04% | final price |
| ILMN | two days later | -8.19% | final price |
| ILMN | three days later | -5.93% | final price |
| ILMN | three days earlier | +27.87% | final price |
| ILMN | five days earlier | +23.35% | final price |
| PACB | that day | +4.27% | final price |
| PACB | the next day | +9.62% | final price |
| PACB | two days later | +3.21% | final price |
| PACB | three days later | -3.85% | final price |
| PACB | three days earlier | +24.36% | final price |
| PACB | five days earlier | +4.70% | final price |
| RVTY | that day | +7.87% | final price |
| RVTY | the next day | +5.12% | final price |
| RVTY | two days later | -0.56% | final price |
| RVTY | three days later | +2.26% | final price |
| RVTY | three days earlier | +9.26% | final price |
| RVTY | five days earlier | +6.78% | final price |
| WAT | that day | +2.27% | final price |
| WAT | the next day | +4.07% | final price |
| WAT | two days later | +0.85% | final price |
| WAT | three days later | +1.86% | final price |
| WAT | three days earlier | +6.80% | final price |
| WAT | five days earlier | +4.21% | final price |
| XLI | that day | +0.95% | final price |
| XLI | the next day | -0.17% | final price |
| XLI | two days later | -4.14% | final price |
| XLI | three days later | -4.16% | final price |
| XLI | three days earlier | +0.22% | final price |
| XLI | five days earlier | -1.06% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Waters (WAT) (jointly held), worth $1,001 - $15,000 on 13 Aug 2026. That is 82 days before publication. Filed 1 Sep 2026. View the filing.
- Rep. Gilbert Cisneros sold Revvity (RVTY), worth $15,001 - $50,000 on 9 Sep 2026. That is 55 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Gilbert Cisneros sold Revvity (RVTY), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Gilbert Cisneros sold Revvity (RVTY), worth $1,001 - $15,000 on 3 Sep 2026. That is 61 days before publication. Filed 12 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“PacBio (PACB) reports Q3: everything you need to know ahead of earnings” scores 12 out of 100. The score uses 1 sources.